Loading stock data…
Sotera Health Company (SHC)
$18.59-0.31 (-1.64%)
Market ClosedLast close Sep 8
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Sotera Health Company in the Healthcare sector is trading at $18.59 with a market capitalization of $5.3B. Wall Street consensus targets $22.72 (9 analysts), implying a +22.2% move over the next 12 months. The stock is currently near its 52-week high of $19.85, remaining 10.5% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +22.2% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $321.38M↑ | $280.05M↓ | $303.44M↓ | $311.31M↑ | $294.34M |
| Gross Profit | $177.96M↑ | $147.07M↓ | $165.92M↓ | $177.56M↑ | $166.62M |
| Operating Income | $106.79M↑ | $75.83M↓ | $105.38M↓ | $111.18M↑ | $88.43M |
| Net Income | $53.64M↑ | $26.59M↓ | $34.85M↓ | $48.40M↑ | $7.96M |
Peer Comparison
JNJUNHPFE
Fundamentals
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and N...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.31B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
32.61
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.78
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
24.56%
Volume
Today's trading volume
2.02M
Recent News
3 Profitable Stocks We Think Twice About
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Research Tools & Consumables Stocks Q2 Recap: Benchmarking Sotera Health Company (NASDAQ:SHC)
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the research tools & consumables industry, including Sotera Health Company (NASDAQ:SHC) and its peers.
Sotera Health Company (SHC): Buy, Sell, or Hold Post Q2 Earnings?
Sotera Health Company trades at $19.02 per share and has stayed right on track with the overall market, gaining 11.3% over the last six months. At the same time, the S&P 500 has returned 13.1%.
Sotera Health Company’s Q2 Earnings Call: Our Top 5 Analyst Questions
Sotera Health’s second quarter was marked by broad-based growth across its business units, which drove a positive market reaction. Management credited robust demand in both core sterilization (Sterigenics) and isotope supply (Nordion), coupled with improved customer engagement at Nelson Labs, for the outperformance. CEO Alton Shader highlighted that "Sterigenics built on strong momentum from Q1, delivering 7% constant currency revenue growth," while Nordion benefited from favorable Cobalt-60 shi
Sotera Health (SHC) Q2 2026 Earnings Call Transcript
Revenue hit $321 million with adjusted EPS up 30% year over year.